ADAM10 and neoplasm: IT was found that miR-140-3p is the miRNA that acts on ADAM10, miR-140-3p can inhibit the activity of the Notch pathway by acting on ADAM10, and ultimately up-regulates the sensitivity of lung adenocarcinoma cells to anti-tumor drugs.